🇨🇭 Switzerland Country × Condition
parkinson disease Clinical Trials in Switzerland
Active clinical trials for parkinson disease with research sites in Switzerland. All data sourced live from ClinicalTrials.gov — updated daily.
Active Trials: 3 // Recruiting: 3 // Updated: Daily
Total Trials
3
Recruiting Now
3
Country
🇨🇭 Switzerland
Active Trials in Switzerland (3)
NCT06386497
Recruiting
Acceptability of the Somnomat Casa for the Treatment of Parkinson's Disease
Enrollment
15 pts
Country
🇨🇭 Switzerland
Insel Gruppe AG, University Hospita...
View Trial → NCT06629207
Recruiting
Artificial Intelligence in Molecular Imaging: Predicting Parkinson's Risk in REM Sleep Behavior Disorder
Enrollment
20 pts
Country
🇨🇭 Switzerland
Insel Gruppe AG, University Hospita...
View Trial → NCT05765110
Recruiting
SPEECH as Biomarker for Emotion, Movement and cOgnition in Parkinson's Disease
Enrollment
80 pts
Country
🇨🇭 Switzerland
Insel Gruppe AG, University Hospita...
View Trial → Frequently Asked Questions
How many parkinson disease clinical trials are active in Switzerland?
There are currently 3 active clinical trials for parkinson disease with sites in Switzerland, of which 3 are actively recruiting patients.
How can I join a parkinson disease clinical trial in Switzerland?
To join a parkinson disease clinical trial in Switzerland, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in Switzerland directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are parkinson disease trials in Switzerland?
Active parkinson disease trials in Switzerland span multiple phases. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology